ARCADIA, Fla., Jan. 31, 2016 -- Sevigny & Associates Eye Care works to prevent common eye disease and provides early detection and management of diagnosed disorders. According to the Centers for Disease Control, macular degeneration, diabetic retinopathy, and glaucoma are the most common eye diseases. Early detection and intervention in these incurable conditions are key in reducing vision loss. The CDC predicts that age-related macular degeneration will affect up to 2.95 million individuals by 2020. Chronic disease such as diabetes and hypertension put patients at risk for diabetic retinopathy and glaucoma. According to the CDC, diabetic retinopathy is the leading cause of blindness among working adults.
According to Dr. Mark Sevigny of Sevigny & Associates Eye Care, regular eye examinations are the front line in the fight against degenerative eye diseases. "Some of our most terrible degenerative eye disease like glaucoma and macular degeneration begin without any symptoms. A patient may be feeling fine, and have no discernable change in their vision, but we can detect these disease in their earliest stages. Once detected, early intervention with topical medications like eye drops or oral medication can slow the progress of conditions like glaucoma or macular degeneration."
According to Dr. Sevigny, "Open and honest communication with an eye doctor is crucial to receiving appropriate care. When we know that a patient has other medical conditions that put them at risk for eye disease we can tailor our care accordingly. Patients may not like to admit that they are diabetic or hypertensive, but if they do not tell us, they are omitting an important piece of data that informs their care." Sevigny & Associates Eye Care uses state-of-the-art diagnostic techniques such as Ocular Coherence Tomography (OCT), Visual Evoked Potential (VEP), and electroretinography (ERG) to promote early detection of degenerative eye disease. These simple tests detect important changes in the eye structure or pressure that can indicate early stages of eye disease.
"About half of the people who are at risk, but do not already have a vision impairment that requires correction, are not coming in for regular eye examinations," stated Dr. Sevigny. "This is a critical mistake. By the time they notice vision loss, these diseases are fairly advanced. When patients with chronic conditions that place them at a greater risk for vision loss receive regular examinations, we can often prevent vision impairment with lifestyle changes, management of their disease, and early treatment for vision conditions."
To make an appointment, contact Sevigny & Associates Eye Care at 863-773-3322. Our Wauchula, Arcadia and Sebring eye clinics are open from 8:00 AM to 5:00 PM, Monday through Friday, and on Saturdays by appointment only. Visit Sevigny & Associates Eye Care online at http://7eeye.com/ for more information.
Sevigny & Associates Eye Care, 863-773-3322


China Adds MP Materials, USA Rare Earth to Export Control List Amid Escalating U.S.-China Trade Tensions
100+ Global Companies Push Governments to Prioritize Electrification for Economic Growth
Nissan Halts Electric Qashqai Development Amid EV Market Challenges
California Drivers Sue BP, Walmart, 7-Eleven Over Alleged AI Gas Price Fixing
SK Hynix Overtakes Samsung as South Korea’s Most Valuable Company
Trump’s Quantum Push Lifts IBM Stock as CEO Arvind Krishna Receives White House Praise
NTSB Investigates Boston Logan Airport Near-Miss Between Delta and American Airlines Jets
TD Bank Expands Employee Monitoring Software to Boost Productivity Amid Privacy Concerns
NHTSA Investigates Fatal Tesla Model 3 Crash in Texas Amid Ongoing Autopilot and FSD Safety Scrutiny
Baseten Secures $1.5 Billion Funding at $13 Billion Valuation Amid AI Infrastructure Boom
DOJ Opens Investigation Into NYC Coffee Shop Over Anti-Goldman Social Media Post
US-Iran De-Escalation Shifts Washington’s Focus to AI Regulation and Crypto Legislation
WiseTech Global Denies Knowledge of Investigation Into Founder Richard White
Oracle Cuts 21,000 Jobs as AI Reshapes Workforce and Cloud Expansion Accelerates
Qualcomm Nears $4 Billion Acquisition of AI Chip Startup Modular
John Jumper Leaves Google DeepMind for Anthropic Amid Intensifying AI Talent Race
JPMorgan Sees Strong Strategic Value in Potential AbbVie Acquisition of Apogee Therapeutics 



